Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Apr 5;4(4):CD002748.
doi: 10.1002/14651858.CD002748.pub4.

Risk-reducing mastectomy for the prevention of primary breast cancer

Nora E Carbine  1 , Liz Lostumbo, Judi Wallace, Henry Ko
Affiliations
Meta-Analysis

Risk-reducing mastectomy for the prevention of primary breast cancer

Nora E Carbine et al. Cochrane Database Syst Rev. .

Abstract

Background: Recent progress in understanding the genetic basis of breast cancer and widely publicized reports of celebrities undergoing risk-reducing mastectomy (RRM) have increased interest in RRM as a method of preventing breast cancer. This is an update of a Cochrane Review first published in 2004 and previously updated in 2006 and 2010.

Objectives: (i) To determine whether risk-reducing mastectomy reduces death rates from any cause in women who have never had breast cancer and in women who have a history of breast cancer in one breast, and (ii) to examine the effect of risk-reducing mastectomy on other endpoints, including breast cancer incidence, breast cancer mortality, disease-free survival, physical morbidity, and psychosocial outcomes.

Search methods: For this Review update, we searched Cochrane Breast Cancer's Specialized Register, MEDLINE, Embase and the WHO International Clinical Trials Registry Platform (ICTRP) on 9 July 2016. We included studies in English.

Selection criteria: Participants included women at risk for breast cancer in at least one breast. Interventions included all types of mastectomy performed for the purpose of preventing breast cancer.

Data collection and analysis: At least two review authors independently abstracted data from each report. We summarized data descriptively; quantitative meta-analysis was not feasible due to heterogeneity of study designs and insufficient reporting. We analyzed data separately for bilateral risk-reducing mastectomy (BRRM) and contralateral risk-reducing mastectomy (CRRM). Four review authors assessed the methodological quality to determine whether or not the methods used sufficiently minimized selection bias, performance bias, detection bias, and attrition bias.

Main results: All 61 included studies were observational studies with some methodological limitations; randomized trials were absent. The studies presented data on 15,077 women with a wide range of risk factors for breast cancer, who underwent RRM.Twenty-one BRRM studies looking at the incidence of breast cancer or disease-specific mortality, or both, reported reductions after BRRM, particularly for those women with BRCA1/2 mutations. Twenty-six CRRM studies consistently reported reductions in incidence of contralateral breast cancer but were inconsistent about improvements in disease-specific survival. Seven studies attempted to control for multiple differences between intervention groups and showed no overall survival advantage for CRRM. Another study showed significantly improved survival following CRRM, but after adjusting for bilateral risk-reducing salpingo-oophorectomy (BRRSO), the CRRM effect on all-cause mortality was no longer significant.Twenty studies assessed psychosocial measures; most reported high levels of satisfaction with the decision to have RRM but greater variation in satisfaction with cosmetic results. Worry over breast cancer was significantly reduced after BRRM when compared both to baseline worry levels and to the groups who opted for surveillance rather than BRRM, but there was diminished satisfaction with body image and sexual feelings.Seventeen case series reporting on adverse events from RRM with or without reconstruction reported rates of unanticipated reoperations from 4% in those without reconstruction to 64% in participants with reconstruction.In women who have had cancer in one breast, removing the other breast may reduce the incidence of cancer in that other breast, but there is insufficient evidence that this improves survival because of the continuing risk of recurrence or metastases from the original cancer. Additionally, thought should be given to other options to reduce breast cancer risk, such as BRRSO and chemoprevention, when considering RRM.

Authors' conclusions: While published observational studies demonstrated that BRRM was effective in reducing both the incidence of, and death from, breast cancer, more rigorous prospective studies are suggested. BRRM should be considered only among those at high risk of disease, for example, BRCA1/2 carriers. CRRM was shown to reduce the incidence of contralateral breast cancer, but there is insufficient evidence that CRRM improves survival, and studies that control for multiple confounding variables are recommended. It is possible that selection bias in terms of healthier, younger women being recommended for or choosing CRRM produces better overall survival numbers for CRRM. Given the number of women who may be over-treated with BRRM/CRRM, it is critical that women and clinicians understand the true risk for each individual woman before considering surgery. Additionally, thought should be given to other options to reduce breast cancer risk, such as BRRSO and chemoprevention when considering RRM.

PubMed Disclaimer

Conflict of interest statement

N Carbine: none L Lostumbo: none J Wallace: none H Ko: none

Figures

1
1
6Study flow diagram.
2
2
Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Altschuler 2008 {published data only}
    1. Altschuler A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, et al. Positive, negative, and disparate‐‐women's differing long‐term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast Journal 2008;14(1):25‐32. - PubMed
Arver 2011 {published data only}
    1. Arver B, Isaksson K, Atterhem H, Baan A, Bergkvist L, Brandberg Y, et al. Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey. Annals of Surgery 2011;253(6):1147‐54. - PubMed
Barton 2005 {published data only}
    1. Barton MB, West CN, Liu IL, Harris EL, Rolnick SJ, Elmore JG, et al. Complications following bilateral prophylactic mastectomy. Journal of the National Cancer Institute. Monographs 2005;35:61‐6. - PubMed
Bedrosian 2010 {published data only}
    1. Bedrosian I, Hu CY, Chang GJ. Population‐based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. Journal of the National Cancer Institute 2010;102(6):401‐9. - PMC - PubMed
Borgen 1998 {published data only}
    1. Borgen PI, Hill AD, Tran KN, Zee KJ, Massie MJ, Payne D, et al. Patient regrets after bilateral prophylactic mastectomy. Annals of Surgical Oncology 1998;5(7):603‐6. - PubMed
Boughey 2010 {published data only}
    1. Boughey JC, Hoskin TL, Degnim AC, Sellers TA, Johnson JL, Kasner MJ, et al. Contralateral prophylactic mastectomy is associated with a survival advantage in high‐risk women with a personal history of breast cancer. Annals of Surgical Oncology 2010;17(10):2702‐9. - PMC - PubMed
Brandberg 2008 {published data only}
    1. Brandberg Y, Arver B, Johansson H, Wickman M, Sandelin K, Liljegren A. Less correspondence between expectations before and cosmetic results after risk‐reducing mastectomy in women who are mutation carriers: a prospective study. European Journal of Surgical Oncology 2012;38(1):38‐43. - PubMed
    1. Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1‐year follow‐up study. Journal of Clinical Oncology 2008;26(24):3943‐9. - PubMed
Bresser 2006 {published data only}
    1. Bresser PJ, Seynaeve C, Gool AR, Brekelmans CT, Meijers‐Heijboer H, Geel AN, et al. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plastic and Reconstructive Surgery 2006;117(6):1675‐82; discussion 1683‐4. - PubMed
Brewster 2012 {published data only}
    1. Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, et al. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 2012;118(22):5637‐43. - PMC - PubMed
Chung 2012 {published data only}
    1. Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Annals of Surgical Oncology 2012;19(8):2600‐6. - PubMed
Contant 2002 {published data only}
    1. Contant CM, Menke‐Pluijmers MB, Seynaeve C, Meijers‐Heijboer EJ, Klijn JG, Verhoog LC, et al. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ‐line mutation. European Journal of Surgical Oncology 2002;28(6):627‐32. - PubMed
de la Pena‐Salcedo 2012 {published data only}
    1. Pena‐Salcedo JA, Soto‐Miranda MA, Lopez‐Salguero JF. Prophylactic mastectomy: is it worth it?. Aesthetic Surgery Journal 2012;36(1):140‐8. - PubMed
Den Heijer 2012 {published data only}
    1. Heijer M, Seynaeve C, Timman R, Duivenvoorden HJ, Vanheusden K, Tilanus‐Linthorst M, et al. Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long‐term follow‐up study. European Journal of Cancer 2012;48(9):1263‐8. - PubMed
Evans 1999 {published data only}
    1. Evans DG, Anderson E, Lalloo F, Vasen H, Beckmann M, Eccles D, et al. Utilisation of prophylactic mastectomy in 10 European centres. Disease Markers 1999;15(1‐3):148‐51. - PMC - PubMed
Evans 2013 {published data only}
    1. Evans DG, Ingham SL, Baildam A, Ross GL, Lalloo F, Buchan I, et al. Contralateral mastectomy improves survival in women with BRCA1/2‐associated breast cancer. Breast Cancer Research and Treatment 2013;140(1):135‐42. - PubMed
Frost 2000 {published data only}
    1. Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE, et al. Long‐term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 2000;284(3):319‐24. - PubMed
Frost 2005 {published data only}
    1. Boughey JC, Hoskin TL, Hartmann LC, Johnson JL, Jacobson SR, Degnim AC, et al. Impact of reconstruction and reoperation on long‐term patient‐reported satisfaction after contralateral prophylactic mastectomy. Annals of Surgical Oncology 2015;22(2):401‐8. - PMC - PubMed
    1. Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC. Contralateral prophylactic mastectomy: long‐term consistency of satisfaction and adverse effects and the significance of informed decision‐making, quality of life, and personality traits. Annals of Surgical Oncology 2011;18(11):3110‐6. - PMC - PubMed
    1. Frost MH, Slezak JM, Tran NV, Williams CI, Johnson JL, Woods JE, et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. Journal of Clinical Oncology 2005;23(31):7849‐56. - PubMed
Gabriel 1997 {published data only}
    1. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT, Melton LJ 3rd. Complications leading to surgery after breast implantation. New England Journal of Medicine 1997;336(10):677‐82. - PubMed
Gahm 2007 {published data only}
    1. Gahm J, Jurell G, Wickman M, Hansson P. Sensitivity after bilateral prophylactic mastectomy and immediate reconstruction. Scandinavian Journal of Plastic & Reconstructive Surgery & Hand Surgery 2007;41(4):178‐83. - PubMed
Gahm 2010 {published data only}
    1. Gahm J, Hansson P, Brandberg Y, Wickman M. Breast sensibility after bilateral risk‐reducing mastectomy and immediate breast reconstruction: a prospective study. Journal of Plastic, Reconstructive and Aesthetic Surgery 2013;66(11):1521‐7. - PubMed
    1. Gahm J, Wickman M, Brandberg Y. Bilateral prophylactic mastectomy in women with inherited risk of breast cancer‐‐prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 2010;19(6):462‐9. - PubMed
Geiger 2005 {published data only}
    1. Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, et al. A population‐based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Archives of Internal Medicine 2005;165(5):516‐20. - PubMed
Geiger 2006 {published data only}
    1. Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. Journal of Clinical Oncology 2006;24(9):1350‐6. - PubMed
Geiger 2007 {published data only}
    1. Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, et al. Quality of life after bilateral prophylactic mastectomy. Annals of Surgical Oncology 2007;14(2):686‐94. - PubMed
Goldflam 2004 {published data only}
    1. Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 2004;101(9):1977‐86. - PubMed
Gopie 2013 {published data only}
    1. Gopie JP, Mureau MA, Seynaeve C, Ter Kuile MM, Menke‐Pluymers MB, Timman R, et al. Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Familial cancer 2013;12(3):479‐87. - PubMed
Hartmann 1999a {published data only}
    1. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Armold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New England Journal of Medicine 1999;340(2):77‐84. - PubMed
Hartmann 2001 {published data only}
    1. Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta D, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute 2001;93(21):1633‐7. - PubMed
Hatcher 2001 {published data only}
    1. Hatcher M, Fallowfield L, A'Hern R. The psychological impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 2001;322(7278):76‐9. - PMC - PubMed
Heemskerk‐Gerritsen 2013 {published data only}
    1. Heemskerk‐Gerritsen BA, Brekelmans CT, Menke‐Pluymers MB, Geel AN, Tilanus‐Linthorst MM, Bartels CC, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long‐term experiences at the Rotterdam Family Cancer Clinic. Annals of Surgical Oncology 2007;14(12):3335‐44. - PMC - PubMed
    1. Heemskerk‐Gerritsen BA, Menke‐Pluijmers MB, Jager A, Tilanus‐Linthorst MM, Koppert LB, Obdeijn IM, et al. Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis. Annals of Oncology 2013;24(8):2029‐35. - PubMed
Heemskerk‐Gerritsen 2015 {published data only}
    1. Heemskerk‐Gerritsen BA, Rookus MA, Aalfs CM, Auseums MG, Collée JM, Jansen L, et al. Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. International Journal of Cancer 2015;136(3):668‐77. - PubMed
Herrinton 2005 {published data only}
    1. Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a Cancer Research Network project. Journal of Clinical Oncology 2005;23(19):4275‐86. - PubMed
Hopwood 2000 {published data only}
    1. Hopwood P, Lee A, Shenton A, Baildam A, Brain A, Lalloo F, et al. Clinical followup after bilateral risk reducing (prophylactic) mastectomy: mental health and body image outcomes. Psycho‐oncology 2000;9(6):462‐72. - PubMed
Horton 1978 {published data only}
    1. Horton CE, Rosato FE, Schuler FA 3d, McGraw J. Postmastectomy reconstruction. Annals of Surgery 1978;188(6):773‐7. - PMC - PubMed
Hwang 2016 {published data only}
    1. Hwang ES, Locklear TD, Rushing CN, Samsa G, Abernethy AP, Hyslop T, et al. Patient‐reported outcomes after choice for contralateral prophylactic mastectomy. Journal of Clinical Oncology 2016;34(13):1518‐27. - PubMed
Ingham 2013 {published data only}
    1. Ingham SL, Sperrin M, Baildam A, Ross GL, Clayton R, Lalloo F, et al. Risk‐reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral. Breast Cancer Research & Treatment 2013;142(3):611‐8. - PubMed
Isern 2008 {published data only}
    1. Isern AE, Tengrup I, Loman N, Olsson H, Ringberg A. Aesthetic outcome, patient satisfaction, and health‐related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery 2008;61(10):1177‐87. - PubMed
Jatoi 2014 {published data only}
    1. Jatoi I, Parsons HM. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Research & Treatment 2014;148(2):389‐96. - PMC - PubMed
Kass 2010 {published data only}
    1. Kaas R, Verhoef S, Wesseling J, Rookus MA, Oldenburg HS, Peeters MJ, et al. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer. Annals of Surgery 2010;251(3):488‐92. - PubMed
Kiely 2010 {published data only}
    1. Kiely BE, Jenkins MA, McKinley JM, Friedlander ML, Milne RL, McLachland SA, et al. Contralateral risk‐reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high‐risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Breast Cancer Research and Treatment 2010;120(3):715‐23. - PubMed
King 2011a {published data only}
    1. King TA, Sakr P, Patil S, Gurevich I, Stempel M, Sampson M, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. Journal of Clinical Oncology 2011;29(16):2158‐64. - PubMed
Koskenvuo 2014 {published data only}
    1. Koskenvuo L, Svarvar C, Suominen S, Aittomaki K, Jahkola T. The frequency and outcome of breast cancer risk‐reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers. Scandinavian Journal of Surgery 2014;103(1):34‐40. - PubMed
Kruper 2014 {published data only}
    1. Kruper L, Kauffmann RM, Smith DD, Nelson RA. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias. Annals of Surgical Oncology 2014;21(11):3348‐56. - PubMed
Lee 1995 {published data only}
    1. Lee JS, Grant CS, Donohue JH, Crotty TB, Harmsen WS, Ilstrup DM. Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery 1995;118(4):640‐7. - PubMed
Leis 1981 {published data only}
    1. Leis HP, Cammarata A, LaRaja R, Reed L, Cleary J, Makoon‐Singh E. Bilateral breast cancer. Breast 1981;7(4):13‐7.
McDonnell 2001 {published data only}
    1. McDonnell SK, Schaid DJ, Myers JL, Grant CS, Donohue JH, Woods JE, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. Journal of Clinical Oncology 2001;19(19):3938‐43. - PubMed
Meijers‐Heijboer 2001 {published data only}
    1. Klijn JGM, Geel AN, Meijers‐Heijboer H, Tilanus‐Linthorst M, Bartels CCM, Crepin CMG, et al. Results of extended series on prophylactic mastectomy versus surveillance in BRCA1/2 mutation carriers in Rotterdam. 27th Annual The Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium (SABCS) 2004;1:S10.
    1. Meijers‐Heijboer H, Geel B, Putten WL, Henzen‐Logmans SC, Seynaeve C, Menke‐Pluymers MB, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of Medicine 2001;345(3):159‐64. - PubMed
Metcalfe 2004b {published data only}
    1. Metcalfe KA, Esplen MJ, Goel V, Narod SA. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho‐oncology 2004;13(1):14‐25. - PubMed
Metcalfe 2005 {published data only}
    1. Metcalfe KA, Esplen MJ, Goel V, Narod SA. Predictors of quality of life in women with a bilateral prophylactic mastectomy. Breast Journal 2005;11(1):65‐9. - PubMed
Metcalfe 2014 {published data only}
    1. Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, et al. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 2014;348:g226. - PMC - PubMed
    1. Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology 2004;22(12):2328‐35. - PubMed
Miller 2013 {published data only}
    1. Miller ME, Czechura T, Martz B, Hall ME, Pesce C, Jaskowiak N, et al. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Annals of Surgical Oncology 2013;20(13):4113‐20. - PubMed
Montgomery 1999 {published data only}
    1. Montgomery LL, Tran KN, Heelan MC, Zee KJ, Massie MJ, Payne DK, et al. Issues of regret in women with contralateral prophylactic mastectomies. Annals of Surgical Oncology 1999;6(6):546‐52. - PubMed
Mutter 2015 {published data only}
    1. Mutter RW, Frost MH, Hoskin TL, Johnson JL, Hartmann LC, Boughey JC. Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes. Breast Cancer Research & Treatment 2015;153(1):183‐90. - PMC - PubMed
Pennisi 1989 {published data only}
    1. Pennisi VR, Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plastic Surgery 1989;13(1):15‐21. - PubMed
Peralta 2000 {published data only}
    1. Peralta E, Ellenhorn J, Wagman L, Dagis A, Anderson J, Chu D. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. American Journal of Surgery 2000;180(6):439‐45. - PubMed
Pesce 2014 {published data only}
    1. Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor‐negative breast cancer. Annals of Surgical Oncology 2014;21(10):3231‐9. - PubMed
Rebbeck 2004 {published data only}
    1. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, 't Veer L, Garber JE, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Journal of Clinical Oncology 2004;22(6):1055‐62. - PubMed
Skytte 2011 {published data only}
    1. Skytte AB, Cruger D, Gerster M, Laenkholm AV, Lang C, Brondum‐Nielsen K, et al. Breast cancer after bilateral risk‐reducing mastectomy. Clinical Genetics 2011;79(5):431‐7. - PubMed
Unukovych 2012 {published data only}
    1. Unukovych D, Sandelin K, Liljegren A, Arver B, Wickman M, Johansson H, et al. Contralateral prophylactic mastectomy in breast cancer patients with a family history: a prospective 2‐years follow‐up study of health related quality of life, sexuality and body image. European Journal of Cancer 2012;48(17):3150‐6. - PubMed
    1. Unukovych D, Wickman M, Sandelin K, Arver B, Johansson H, Brandberg Y. Associations between reoperations and psychological factors after contralateral risk‐reducing mastectomy: a two‐year follow‐up study. International Journal of Breast Cancer 2016;2016(ID 4604852):1‐7. - PMC - PubMed
Van Sprundel 2005 {published data only}
    1. Sprundel TC, Schmidt MK, Rookus MA, Brohet R, Asperen CJ, Rutgers EJ, et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. British Journal of Cancer 2005;93(3):287‐92. - PMC - PubMed
Zeichner 2014 {published data only}
    1. Zeichner SB, Zeichner SB, Ruiz AL, Markward NJ, Rodriguez E. Improved long‐term survival with contralateral prophylactic mastectomy among young women. Asian Pacific Journal of Cancer Prevention 2014;15(3):1155‐62. - PubMed
Zion 2003 {published data only}
    1. Zion S, Slezak J, Schaid D, Frost M, McDonnell S, Woods J, et al. Surgical morbidities following bilateral prophylactic mastectomy. ASCO Abstract No: 1730 Category: Health Services. 2000.
    1. Zion SM, Slezak JM, Sellers TA, Woods JE, Arnold PG, Petty PM, et al. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 2003;98(10):2152‐60. - PubMed

References to studies excluded from this review

Abbott 2011 {published data only}
    1. Abbott A, Rueth N, Pappas‐Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Annals of Surgical Oncology 2011;18(11):3129‐36. - PubMed
Ager 2016 {published data only}
    1. Ager B, Butow P, Jansen J, Phillips KA, Porter D. Contralateral prophylactic mastectomy (CPM): a systematic review of patient reported factors and psychological predictors influencing choice and satisfaction. Breast 2016;28:107‐20. - PubMed
Alamounti 2015 {published data only}
    1. Alamouti R, Hachach‐Haram N, Farhadi J. Multidisciplinary management of risk‐reducing mastectomy and immediate reconstruction: treatment algorithm and patient satisfaction. European Journal of Plastic Surgery 2015;38(5):385‐90.
Antill 2006 {published data only}
    1. Antill Y, Reynolds J, Young MA, Kirk J, Tucker K, Bogtstra T, et al. Risk‐reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. European Journal of Cancer 2006;42(5):621‐8. - PubMed
Ariyan 1985 {published data only}
    1. Ariyan S. Prophylactic mastectomy for precancerous and high‐risk lesions of the breast. Canadian Journal of Surgery 1985;28(3):262‐4. - PubMed
Babiera 1997 {published data only}
    1. Babiera GV, Lowy AM, Davidson BS, Singletary SE. The role of contralateral prophylactic mastectomy in invasive lobular carcinoma. Breast Journal 1997;3(1):2‐6.
Barry 2012 {published data only}
    1. Barry PN, Johnson RR, Harkenrider MM, Freeman AB, Kruse B, Wilson MR, et al. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database. American Journal of the Medical Sciences 2012;344(6):452‐6. - PubMed
Bebbington Hatcher 2003 {published data only}
    1. Bebbington Hatcher M, Fallowfield LJ. A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. Breast 2003;12(1):1‐9. - PubMed
Blackburn 2016 {published data only}
    1. Blackburn A, Taghizadeh R, Hughes D, O'Donoghue JM. Prevention of perioperative limb neuropathies in abdominal free flap breast reconstruction. Journal of Plastic, Reconstructive and Aesthetic Surgery 2016;69(1):48‐54. - PubMed
Borreani 2014 {published data only}
    1. Borreani C, Manoukian S, Bianchi E, Brunelli C, Peissel B, Caruso A, et al. The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers. Clinical Genetics 2014;85(1):7‐15. - PubMed
Bostwick 1980 {published data only}
    1. Bostwick J. Reconstruction of the breast. Acta Chirurgica Belgica 1980;79(2):125‐9. - PubMed
Brekelmans 2006 {published data only}
    1. Brekelmans CT, Seynaeve C, Menke‐Pluymers M, Brüggenwirth HT, Tilanus‐Linthorst MM, Bartels CC, et al. Survival and prognostic factors in BRCA1‐associated breast cancer. Annals of Oncology 2006;17(3):391‐400. - PubMed
Brinton 2001 {published data only}
    1. Brinton LA, Persson I, Boice JD Jr, McLaughlin JK, Fraumeni JF Jr. Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer 2001;91(3):478‐83. - PubMed
Brown 2005 {published data only}
    1. Brown KL, Hutchison R, Zinberg RE, McGovern MM. Referral and experience with genetic testing among women with early onset breast cancer. Genetic Testing 2005;9(4):301‐5. - PubMed
Buehler 1983 {published data only}
    1. Buehler PK. Patient selection for prophylactic mastectomy: who is at high risk?. Plastic and Reconstructive Surgery 1983;72(3):324‐34. - PubMed
Collins 2013 {published data only}
    1. Collins IM, Milne RL, Weideman PC, McLachlan SA, Friedlander ML, Hopper JL, et al. Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriers. Medical Journal of Australia 2013;199(10):680‐3. - PubMed
Cortesi 2014 {published data only}
    1. Cortesi L, Razzaboni E, Toss A, Matteis E, Marchi I, Medici V, et al. A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk‐reducing mastectomy in BRCA1/2‐positive Italian women. Annals of Oncology 2014;25(1):57‐63. - PubMed
Dikmans 2016 {published data only}
    1. Dikmans RE, Morabit F, Ottenhof MJ, Tuinder SM, Twisk JW, Moues C, et al. Single‐stage breast reconstruction using Strattice: a retrospective study. Journal of Plastic, Reconstructive and Aesthetic Surgery 2016;69(2):227‐33. - PubMed
Dinner 1981 {published data only}
    1. Dinner MI, Labandter HP. Total mammary adenectomy with histologic evaluation and immediate reconstruction. Plastic and Reconstructive Surgery 1981;68(4):505‐11. - PubMed
Domchek 2011 {published data only}
    1. Domchek SM, Friebel TM, Singer CF, Gareth Evans D, Lynch HT, Isaacs C, et al. Association of risk‐reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. Journal of the American Medical Association 2010;304(9):967‐75. - PMC - PubMed
Eisinger 2001 {published data only}
    1. Eisinger F, Stoppa‐Lyonnet D, Lasset C, Vennin P, Chabal F, Noguès C, et al. Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys. Familial Cancer 2001;1(3‐4):157‐62. - PubMed
Evans 2005 {published data only}
    1. Evans DG, Lalloo F, Hopwood P, Maurice A, Baildam A, Brain A, et al. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years. European Journal of Surgical Oncology 2005;31(10):1112‐8. - PubMed
Fowbie 2015 {published data only}
    1. Fowbie B, Park C, Wang F, Peled A, Alvarado M, Ewing C, et al. Rates of reconstruction failure in patients undergoing immediate reconstruction with tissue expanders and/or implants and postmastectomy radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2015;92(3):634‐41. - PubMed
Fu 2015 {published data only}
    1. Fu Y, Zhuang Z, Dewing M, Apple S, Chang H. Predictors for contralateral prophylactic mastectomy in breast cancer patients. International Journal of Clinical and Experimental Pathology 2015;8(4):3748‐64. - PMC - PubMed
Graham 2015 {published data only}
    1. Graham PJ, Brar MS, Foster T, McCall M, Bouchard‐Fortier A, Temple W, et al. Neoadjuvant chemotherapy for breast cancer, is practice changing? A population‐based review of current surgical trends. Annals of Surgical Oncology 2015;22(10):3376‐82. - PubMed
Gschwantier 2016 {published data only}
    1. Gschwantler‐Kaulich D, Schrenk P, Bjelic‐Radisic V, Unterrieder K, Leser C, Fink‐Retter A, et al. Mesh versus acellular dermal matrix in immediate implant‐based breast reconstruction ‐ a prospective randomized trial. European Journal of Surgical Oncology 2016;42(5):665‐71. - PubMed
Hagen 2014 {published data only}
    1. Hagen AI, Maehle L, Veda N, Vetti HH, Stormorken A, Ludvigsen T, et al. Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers. Breast 2014;23(1):38‐43. - PubMed
Han 2011 {published data only}
    1. Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, et al. Increasing incidence of bilateral mastectomies: the patient perspective. American Journal of Surgery 2011;201(5):615‐8. - PubMed
Heiniger 2015 {published data only}
    1. Heiniger L, Butow PN, Coll J, Bullen T, Wilson J, Baylock B, et al. Long‐term outcomes of risk‐reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer. Familial Cancer 2015;14(1):105‐15. - PubMed
Hoffman 1982 {published data only}
    1. Hoffman S, Pressman PI. Prophylactic mastectomy. The Mount Sinai Journal of Medicine (New York) 1982;49(2):102‐9. - PubMed
Horton 1988 {published data only}
    1. Horton CE, Dascombe WH. Total mastectomy: indications and techniques. Clinics in Plastic Surgery 1988;15(4):677‐87. - PubMed
Houn 1995 {published data only}
    1. Houn F, Helzlsouer KJ, Friedman NB, Stefanek ME. The practice of prophylactic mastectomy: a survey of Maryland surgeons. American Journal of Public Health 1995;85(6):801‐5. - PMC - PubMed
Jarrett 1982 {published data only}
    1. Jarrett JR, Cutler RG, Teal DF. Aesthetic refinements in prophylactic subcutaneous mastectomy with submuscular reconstruction. Plastic and Reconstructive Surgery 1982;69(4):624‐31. - PubMed
Jones 2009 {published data only}
    1. Jones NB, Wilson J, Koture L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Annals of Surgical Oncology 2009;16(10):2691‐6. - PubMed
Josephson 2000 {published data only}
    1. Josephson U, Wickman M, Sandelin K. Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. European Journal of Surgical Oncology 2000;26(4):351‐6. - PubMed
Katapodi 2004 {published data only}
    1. Katapodi MC, Lee KA, Facione NC, Dodd MJ. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta‐analytic review. Preventive Medicine 2004;38(4):388‐402. - PubMed
Kheirelseid 2011 {published data only}
    1. Kheirelseid EA, Jumustafa H, Miller N, Curran C, Sweeney K, Malone C, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Research & Treatment 2011;126(1):131‐40. - PubMed
King 2011b {published data only}
    1. King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M. Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Annals of Surgery 2011;254(1):2‐7. - PubMed
Klitzman 2010 {published data only}
    1. Klitzman R, Chung W. The process of deciding about prophylactic surgery for breast and ovarian cancer: patient questions, uncertainties, and communication. American Journal of Medical Genetics 2010;152A(1):52‐66. - PMC - PubMed
Kurian 2005 {published data only}
    1. Kurian AW, Hartman AR, Mills MA, Ford JM, Daniel BL, Plevritis SK. Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expectations 2005;8(3):221‐33. - PMC - PubMed
Leis 1980 {published data only}
    1. Leis HP Jr. Managing the remaining breast. Cancer 1980;46(4 Suppl):1026‐30. - PubMed
Lerman 1996 {published data only}
    1. Lerman C, Narod S, Schulman K, Hughes C, Gomez‐Caminero A, Bonney G, et al. BRCA1 testing in families with hereditary breast‐ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996;275(24):1885‐92. - PubMed
Litton 2009 {published data only}
    1. Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric‐Bernstam F, et al. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer 2009;115(8):1598‐604. - PMC - PubMed
Lloyd 2000 {published data only}
    1. Lloyd SM, Watson M, Oaker G, Sacks N, Querci della Rovere U, Gui G. Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women. Psycho‐oncology 2000;9(6):473‐85. - PubMed
Lodder 2002 {published data only}
    1. Lodder LN, Frets PG, Trijsburg RW, Meijers‐Heijboer EJ, Klijn JG, Seynaeve C, et al. One year follow‐up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Research & Treatment 2002;7(2):97‐112. - PubMed
Lynch 1991 {published data only}
    1. Lynch HT, Watson P, Conway TA, Lynch J. Monitoring high risk women: psychological aspects. Developments in Oncology 1991;62:191‐205.
Lynch 2006 {published data only}
    1. Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, et al. Patient responses to the disclosure of BRCA mutation tests in hereditary breast‐ovarian cancer families. Cancer Genetics and Cytogenetics 2006;165(2):91‐7. - PubMed
Madlensky 2005 {published data only}
    1. Madlensky L, Flatt SW, Bardwell WA, Rock CL, Pierce JP, WHEL Study group. Is family history related to preventive health behaviors and medical management in breast cancer patients?. Breast Cancer Research and Treatment 2005;90(1):47‐54. - PubMed
McAvoy 1979 {published data only}
    1. McAvoy J. Subcutaneous mastectomy in the treatment of the high‐risk female‐‐is emotionalism obscuring the facts?. Annals of Plastic Surgery 1979;3(3):219‐26. - PubMed
McCready 2007 {published data only}
    1. McCready DR, Escallon J. Clinical considerations regarding contralateral prophylactic mastectomy. Women's Health 2007;3(1):39‐43. - PubMed
Meijers‐Heijboer 2003 {published data only}
    1. Meijers‐Heijboer H, Brekelmans CT, Menke‐Pluymers M, Seynaeve C, Baalbergen A, Burger C, et al. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology 2003;21(9):1675‐81. - PubMed
Metcalfe 2004c {published data only}
    1. Metcalfe KA, Semple JL, Narod SA. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plastic and Reconstructive Surgery 2004;114(2):360‐6. - PubMed
Metcalfe 2008a {published data only}
    1. Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim‐Sing C, Friedman E, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: The Hereditary Breast Cancer Clinical Study Group. Journal of Clinical Oncology 2008;26(7):1093‐7. - PubMed
Metcalfe 2008b {published data only}
    1. Metcalfe KA, Birenbaum‐Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer 2008;122(9):2017‐22. - PMC - PubMed
Metcalfe 2011a {published data only}
    1. Metcalfe K, Lynch HT, Ghadirian P, Tung N, Kim‐Sing C, Olopade OI, et al. Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research & Treatment 2011;127(1):287‐96. - PubMed
Metcalfe 2011b {published data only}
    1. Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim‐Sing C, et al. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer 2011;104(9):1384‐92. - PMC - PubMed
Meyer 1986 {published data only}
    1. Meyer L, Ringberg A. A prospective study of psychiatric and psychological sequelae of bilateral subcutaneous mastectomy. Scandinavian Journal of Plastic and Reconstructive Surgery 1986;20(1):101‐7. - PubMed
Mulvihill 1982 {published data only}
    1. Mulvihill JJ, Safyer AW, Bening JK. Prevention in familial breast cancer: counseling and prophylactic mastectomy. Preventive Medicine 1982;11(5):500‐11. - PubMed
Narod 2011 {published data only}
    1. Narod SA. The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer. Breast Cancer Research & Treatment 2011;128(2):581‐3. - PubMed
Narod 2014 {published data only}
    1. Narod SA. Bilateral breast cancers. Nature Reviews Clinical Oncology 2014;11:157‐66. - PubMed
Nekhlyudov 2005 {published data only}
    1. Nekhlyudov L, Bower M, Herrinton LJ, Altschuler A, Greene SM, Rolnick S, et al. Women's decision‐making roles regarding contralateral prophylactic mastectomy. Journal of the National Cancer Institute. Monographs 2005;35:55‐60. - PubMed
Osman 2013 {published data only}
    1. Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Annals of Surgical Oncology 2013;20(10):3212‐7. - PubMed
Patenaude 2008 {published data only}
    1. Patenaude AF, Orozco S, Li X, Kaelin CM, Gadd M, Matory Y, et al. Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psycho‐oncology 2008;17(8):831‐43. - PMC - PubMed
Payne 2000 {published data only}
    1. Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ. Women's regrets after bilateral prophylactic mastectomy. Annals of Surgical Oncology 2000;7(2):150‐4. - PubMed
Pennisi 1984 {published data only}
    1. Pennisi VR, Capozzi A. Subcutaneous mastectomy: an interim report on 1,244 patients. Annals of Plastic Surgery 1984;12(4):340‐7. - PubMed
Petit 2002 {published data only}
    1. Petit JY, Greco M, EUSOMA. Quality control in prophylactic mastectomy for women at high risk of breast cancer. European Journal of Cancer 2002;38(1):23‐6. - PubMed
Phillips 2006 {published data only}
    1. Phillips KA, Jenkins MA, Lindeman GJ, McLachlan SA, McKinely JM, Weideman PC, et al. Risk‐reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clinical Genetics 2006;70(3):198‐206. - PubMed
Rhiem 2012 {published data only}
    1. Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M, et al. The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Research 2012;14(6):R156. - PMC - PubMed
Ringberg 1982 {published data only}
    1. Ringberg A, Palmer B, Linell F. The contralateral breast at reconstructive surgery after breast cancer operation‐‐a histopathological study. Breast Cancer Research and Treatment 1982;2(2):151‐61. - PubMed
Roberts 2014 {published data only}
    1. Roberts A, Habibi M, Frick KD. Cost‐effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer. Annals of Surgical Oncology 2014;21(7):2209‐17. - PubMed
Roberts 2015 {published data only}
    1. Roberts A, Baxter N, Camacho X, Lau C, Zhong T. Once is rarely enough: a population‐based study of reoperations after postmastectomy breast reconstruction. Annals of Surgical Oncology 2015;22(10):3302‐7. - PubMed
Roinick 2007 {published data only}
    1. Rolnick SJ, Altschuler A, Nekhlyudov L, Elmore JG, Green SM, Harris EL, et al. What women wish they knew before prophylactic mastectomy. Cancer Nursing 207;30(4):285‐91. - PubMed
Rubin 1979 {published data only}
    1. Rubin LR. A preventive mastectomy with immediate reconstruction for the high‐risk breast cancer patient. Clinics in Plastic Surgery 1979;6(1):107‐19. - PubMed
Rueth 2011 {published data only}
    1. Rueth NM, McMahon M, Arrington AK, Swenson K, Leach J, Tuttle TM. Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction. Annals of Surgical Oncology 2011;18(9):2515‐20. - PubMed
Sakorafas 2002 {published data only}
    1. Sakorafas GH. Women at high risk for breast cancer: preventive strategies. The Mount Sinai Journal of Medicine (New York) 2002;69(4):264‐6. - PubMed
Salhab 2010 {published data only}
    1. Salhab M, Bismohun S, Mokbel K. Risk‐reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery. BMC Women's Health 2010;10:28. - PMC - PubMed
Schwartz 2004 {published data only}
    1. Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Journal of Clinical Oncology 2004;22(10):1823‐9. - PubMed
Scott 2003 {published data only}
    1. Scott CI, Iorgulescu DG, Thorne HJ, Henderson MA, Phillips KA, Kathleen Cuningham Foundation Consortium for Familial Breast Cancer (kConFab). Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy. Clinical Genetics 2003;64(2):111‐21. - PubMed
See 2005 {published data only}
    1. See HT, Cheung YB, Yong F, Khoo KS, Ang P. Acceptance of prophylactic surgery and chemoprevention of cancer in Singapore ‐ a survey. Annals of the Academy of Medicine (Singapore) 2005;34(3):238‐42. - PubMed
Snyderman 1984 {published data only}
    1. Snyderman RK. Prophylactic mastectomy: pros and cons. Cancer 1984;53(3 Suppl):803‐8. - PubMed
Spear 2008 {published data only}
    1. Spear SL, Schwarz KA, Venturi ML, Barbosa T, Al‐Attar A. Prophylactic mastectomy and reconstruction: clinical outcomes and patient satisfaction. Plastic & Reconstructive Surgery 2008;122(1):1‐9. - PubMed
Specht 2004 {published data only}
    1. Specht MC, Borgen PI, Fey J, Zhang Z, Sclafani L. Personal health behaviors in women who have undergone risk‐reducing mastectomy. American Journal of Surgery 2004;188(4):448‐9. - PubMed
Stalmeier 2009 {published data only}
    1. Stalmeier PF, Roosmalen MS. Concise evaluation of decision aids. Patient Education & Counseling 2009;74(1):104‐9. - PubMed
Stefanek 1995 {published data only}
    1. Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F. Predictors of satisfaction with bilateral prophylactic mastectomy. Preventive Medicine 1995;24(4):412‐9. - PubMed
Stolier 2005 {published data only}
    1. Stolier AJ, Corsetti RL. Newly diagnosed breast cancer patients choose bilateral mastectomy over breast‐conserving surgery when testing positive for a BRCA1/2 mutation. The American Surgeon 2005;71(12):1031‐3. - PubMed
Stuckey 2010 {published data only}
    1. Stuckey A, Dizon D, Scalia WJ, Kent J, Tejada‐Berges T, Gass J, et al. Clinical characteristics and choices regarding risk‐reducing surgery in BRCA mutation carriers. Gynecologic and Obstetric Investigations 2010;69(4):270‐3. - PubMed
Temple 1991 {published data only}
    1. Temple WJ, Lindsay RL, Magi E, Urbanski SJ. Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. American Journal of Surgery 1991;161(4):413‐5. - PubMed
Tercyak 2007 {published data only}
    1. Tercyak KP, Peshkin BN, Brogan BM, DeMarco T, Pennanen MF, Willey SC, et al. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high‐risk breast cancer patients who underwent BRCA1/2 gene testing. Journal of Clinical Oncology 2007;25(3):285‐91. - PubMed
Theogaraj 1973 {published data only}
    1. Theogaraj SD. Cancer prophylaxis by subcutaneous mastectomy. Indications and recent trends in reconstruction. Virginia Medical Monthly 1973;100(6):545‐50. - PubMed
Tuttle 2007 {published data only}
    1. Tuttle TM, Haberman EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. Journal of Clinical Oncology 2007;25(33):5203‐9. - PubMed
Unic 1998 {published data only}
    1. Unic I, Stalmeier PF, Verhoef LC, Daal WA. Assessment of the time‐tradeoff values for prophylactic mastectomy of women with a suspected genetic predisposition to breast cancer. Medical Decision Making 1998;18(3):268‐77. - PubMed
Van Dijk 2003 {published data only}
    1. Dijk S, Otten W, Zoeteweij MW, Timmermans DR, Asperen CJ, Breuning MH, et al. Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment. British Journal of Cancer 2003;88(11):1675‐81. - PMC - PubMed
von Smitten 2001 {published data only}
    1. Smitten K. Prophylactic breast surgery for women with BRCA1 and BRCA2 germline mutations. Tumori 2001;87(4):S13‐5. - PubMed
Wang 2015a {published data only}
    1. Wang F, Amara D, Peled AW, Sbitany H, Foster RD, Ewing CA, et al. Negative genetic testing does not deter contralateral prophylactic mastectomy in younger patients with greater family histories of breast cancer. Annals of Surgical Oncology 2015;22(10):3338‐45. - PubMed
Wapnir 1990 {published data only}
    1. Wapnir IL, Rabinowitz B, Greco RS. A reappraisal of prophylactic mastectomy. Surgery, Gynecology & Obstetrics 1990;171(2):171‐84. - PubMed
Wasteson 2011 {published data only}
    1. Wasteson E, Sandeline K, Brandberg Y, Wickman M, Arver B. High satisfaction rate ten years after bilateral prophylactic mastectomy ‐ a longitudinal study. 2011 European Journal of Cancer;20(4):508‐13. - PubMed
Yarbro 1985 {published data only}
    1. Yarbro JW. Breast cancer: the new biology in conflict with the old dogma. Seminars in Oncology Nursing 1985;1(3):157‐62. - PubMed
Yi 2010 {published data only}
    1. Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, et al. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prevention Research 2010;3(8):1026‐34. - PMC - PubMed
Zendejas 2011 {published data only}
    1. Zendejas B, Moriarty JP, O'Byrne J, Degnim AC, Farley DR, Boughey JC. Cost‐effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer. Journal of Clinical Oncology 2011;29(22):2993‐3000. - PMC - PubMed

Additional references

ACS 2017
    1. American Cancer Society. Cancer Statistics Center. cancerstatisticscenter.cancer.org/# 2017.
Anderson 2001
    1. Anderson BO. Prophylactic surgery to reduce breast cancer risk: A brief literature review. The Breast Journal 2001;7(5):321‐30. - PubMed
Baasch 1996
    1. Baasch M, Nielsen SF, Engholm G, Lund K. Breast cancer incidence subsequent to surgical reduction of the female breast. British Journal of Cancer 1996;73(7):961‐3. - PMC - PubMed
Barry 2011
    1. Barry M, Sacchini V. When is contralateral mastectomy warranted in unilateral breast cancer?. Expert Review of Anticancer Therapy 2011;11(8):1209‐14. - PubMed
Boughey 2015
    1. Boughey JC, Hoskin TL, Hartmann LC, Johnson JL, Jacobson SR, Degnim AC, et al. Impact of reconstruction and reoperation on long‐term patient‐reported satisfaction after contralateral prophylactic mastectomy. Annals of Surgical Oncology 2015;22(2):401‐8. - PMC - PubMed
Brandberg 2012
    1. Brandberg Y, Arver B, Johansson H, Wickman M, Sandelin K, Liljegren A. Less correspondence between expectations before and cosmetic results after risk‐reducing mastectomy in women who are mutation carriers: a prospective study. European Journal of Surgical Oncology 2012;38(1):38‐43. - PubMed
Brewster 2011
    1. Brewster AM, Parker PA. Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer. Oncology 2011;16(7):935‐41. - PMC - PubMed
Burness 2011
    1. Burness ML, Olopade OI. Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?. Journal of Clinical Oncology 2011;29(13):1652‐4. - PubMed
Carr‐Hill 1992
    1. Carr‐Hill RA. The measurement of patient satisfaction. Journal of Public Health Medicine 1992;14(3):236‐49. - PubMed
Chang 2003
    1. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 2003;97(3):545‐53. - PubMed
Clarke 2002
    1. Clarke M, Oxman AD (eds.). Assessment of study quality. Cochrane reviewers Handbook 4.1.5 [updated April 2002]; Section 4. 2002, issue 2.
Crosby 2011
    1. Crosby MA, Garvey PB, Selber JC, Adelman DM, Sacks JM, Villa MT, et al. Reconstructive outcomes in patients undergoing contralateral prophylactic mastectomy. Plastic & Reconstructive Surgery 2011;12(5):1025‐33. - PubMed
Eisen 2000
    1. Eisen A, Rebbeck TR, Wood WC, Weber BL. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. Journal of Clinical Oncology 2000;18(9):1980‐95. - PubMed
Ernster 1999
    1. Ernster VL. Prophylactic mastectomy in women with a high risk of breast cancer. New England Journal of Medicine 1999;340(23):1838. - PubMed
Fayanju 2014
    1. Fayanju OM, Stoll CRT, Fowler S, Colditz GA, Margenthaler JA. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta‐analysis. Annals of Surgery 2014;260:1000‐10. - PMC - PubMed
Ferlay 2013
    1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide. IARC CancerBase globocan.iarc.fr 2013; Vol. 11.
Frost 2011
    1. Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC. Contralateral prophylactic mastectomy: long‐term consistency of satisfaction and adverse effects and the significance of informed decision‐making, quality of life, and personality traits. Annals of Surgical Oncology 2011;18(11):3110‐6. - PMC - PubMed
Fryzek 2005
    1. Fryzek JP, Ye W, Nyren O, Tarone RE, Lipworth L, McLaughlin JK. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women. Breast Cancer Research and Treatment 2006;97(2):131‐4. - PubMed
Gahm 2013
    1. Gahm J, Hansson P, Brandberg Y, Wickman M. Breast sensibility after bilateral risk‐reducing mastectomy and immediate breast reconstruction: a prospective study. Journal of Plastic, Reconstructive & Aesthetic Surgery 2013;66(11):1521‐7. - PubMed
Gail 1994
    1. Gail MH, Benichou J. Validation studies on a model for breast cancer risk. Journal of the National Cancer Institute 1994;86(8):573‐5. - PubMed
Ghosh 2002
    1. Ghosh K, Hartmann LC. Current status of prophylactic mastectomy. Oncology 2002;16(10):1319‐25. - PubMed
GLOBOCAN 2012
    1. Global Cancer Observatory, International Agency for Research on Cancer. gco.iarc.fr/ date accessed 28 May 2017.
Gordis 1996
    1. Gordis L. Epidemiology. Philadelphia: WB Saunders, 1996:116‐8.
Hartmann 1999b
    1. Hartmann LC, Schaid DJ, Sellers TA. Prophylactic mastectomy in women with a high risk of breast cancer (The authors reply). New England Journal of Medicine 1999;340(23):1839. - PubMed
Hartmann 2004
    1. Hartmann LC, Degnim A, Schaid DJ. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions. Journal of Clinical Oncology 2004;22(6):981‐3. - PubMed
Haynes 1990
    1. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Annals of Internal Medicine 1990;113(1):69‐76. - PubMed
Heemskerk‐Gerritsen 2007
    1. Heemskerk‐Gerritsen BA, Brekelmans CT, Menke‐Pluymers MB, Geel AN, Tilanus‐Linthorst MM, Bartels CC, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long‐term experiences at the Rotterdam Family Cancer Clinic. Annals of Surgical Oncology 2007;14(12):3335‐44. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Homer 2000
    1. Homer JJ, Sheard CE, Jones NS. Cognitive dissonance, the placebo effect and the evaluation of surgical results. Clinical Otolaryngology and Allied Sciences 2000;25(3):195‐9. - PubMed
Johnson 2003
    1. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. Journal of Clinical Oncology 2003;21(7):1404‐11. - PubMed
Klaren 2003
    1. Klaren HM, Van't Veer LJ, Leeuwen FE, Rookus MA. Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation. Journal of the National Cancer Institute 2003;95(13):941‐7. - PubMed
Klijn 2004
    1. Klijn JGM, Geel AN, Meijers‐Heijboer H, Tilanus‐Linthorst M, Bartels CCM, Crepin CMG, et al. Results of extended series on prophylactic mastectomy versus surveillance in BRCA1/2 mutation carriers in Rotterdam. 27th Annual The Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium (SABCS). 2004; Vol. 1:S10.
Kuchenbaecker 2017
    1. Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos‐Blom MJ, et al. Risks of breast, ovarian and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017;317(23):2402‐16. - PubMed
Lise 1997
    1. Lise M, Zavagno G, Meggiolaro F. Prophylactic mastectomy in women at high risk of breast cancer. Forum 1997;7.1(2 Suppl):112‐6.
Lopez 1996
    1. Lopez MJ, Porter KA. The current role of prophylactic mastectomy. The Surgical Clinics of North America 1996;76(2):231‐42. - PubMed
Metcalfe 2002
    1. Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. Journal of National Cancer Institute 2002;94(20):1564‐9. - PubMed
Metcalfe 2004a
    1. Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology 2004;22(12):2328‐35. - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA Statement. PLoS Medicine 6;7:e1000097. [DOI: 10.1371/journal.pmed1000097] - DOI - PMC - PubMed
Newman 2001
    1. Newman L. Despite efficacy of prophylactic mastectomy, procedure finds few enthusiasts. Journal of the National Cancer Institute 2001;93(5):338‐9. - PubMed
Palmieri 1999
    1. Palmieri C. Trial of prophylactic mastectomy is needed. BMJ 1999;318(7197):1556‐7. - PMC - PubMed
Quan 2008
    1. Quan G, Pommier SJ, Pommier RF. Incidence and outcomes of contralateral breast cancers. American Journal of Surgery 2008;195(5):645‐50. - PubMed
Rookus 2002
    1. Rookus DH, Kappas AM, Tsianos E. Role of surgery in the prophylaxis of hereditary cancer syndromes. Annals of Surgical Oncology 2002;9(7):607‐9. - PubMed
Rubin 1991
    1. Rubin HR, Wu AW. Patient satisfaction: its importance and how to measure it. In: Gitnick G editor(s). The Business of Medicine: A Physician's Guide. New York: Elsevier Science Publishing Co, 1991:397‐409.
Shadehi 2005
    1. Shahedi K, Emanuelsson M, Wiklund F, Gronberg H. High risk of contralateral breast carcinoma in women with hereditary/familial non‐BRCA1/BRCA2 breast carcinoma. Cancer 2005;106(6):1237‐42. - PubMed
Stefanek 2001
    1. Stefanek M, Hartmann L, Nelson W. Risk‐reduction mastectomy: clinical issues and research needs. Journal of the National Cancer Institute 2001;93(17):1297‐306. - PubMed
Van den Broek 2016
    1. Broek AJ, 't Veer LJ, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, et al. Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1/2 mutation carriers. Journal of Clinical Oncology 2016;34(5):409‐18. - PubMed
Van Dijk 2008
    1. Dijk S, Roosmalen MS, Otten W, Stalmeier PF. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. Journal of Clinical Oncology 2008;26(14):2358‐63. - PubMed
von Oostrom 2003
    1. Iris van Oostrom, Hanne Meijers‐Heijboer, Litanja N. Lodder, Hugo J. Duivenvoorden, Arthur R. van Gool, Caroline Seynaeve, Conny A. van der Meer, Jan G.M. Klijn, Bert N. van Geel, Curt W. Burger, Juriy W. Wladimiroff, Aad Tibben. Iris van Oostrom, Hanne Meijers‐Heijboer, Litanja N. Lodder, Hugo J. Duivenvoorden, Arthur R. van Gool, Caroline Seynaeve,Conny A. van der Meer, Jan G.M. Klijn, Bert N. van Geel, Curt W. Burger, Juriy W. Wladimiroff, and Aad Tibben. J Clin Oncol 2003;21:3867‐3874. - PubMed
Ware 1988
    1. Ware JE, Hays RD. Methods for measuring patient satisfaction with specific medical encounters. Medical Care 1988;26(4):393‐402. - PubMed
Yao 2010
    1. Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998‐2007. Annals of Surgical Oncology 2010;17(10):2564‐2. - PubMed
Yao 2016
    1. Yao K, Sisco M, Bedrosian I. Contralateral prophylactic mastectomy: current perspectives. International Journal of Women's Health 2016;8(3):213‐22. - PMC - PubMed
Zion 2000
    1. Zion S, Slezak J, Schaid D, Frost M, McDonnell S, Woods J, et al. Surgical morbidities following bilateral prophylactic mastectomy. ASCO Abstract No: 1730 Category: Health Services. 2000.

References to other published versions of this review

Lostumbo 2010
    1. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD002748.pub3] - DOI - PubMed

MeSH terms